DE60239407D1 - Okulare diagnose der alzheimer-krankheit - Google Patents

Okulare diagnose der alzheimer-krankheit

Info

Publication number
DE60239407D1
DE60239407D1 DE60239407T DE60239407T DE60239407D1 DE 60239407 D1 DE60239407 D1 DE 60239407D1 DE 60239407 T DE60239407 T DE 60239407T DE 60239407 T DE60239407 T DE 60239407T DE 60239407 D1 DE60239407 D1 DE 60239407D1
Authority
DE
Germany
Prior art keywords
okular
diagnosis
alzheimer disease
disease
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60239407T
Other languages
English (en)
Inventor
Lee E Goldstein
Leo T Chylack Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
General Hospital Corp
Original Assignee
Brigham and Womens Hospital Inc
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc, General Hospital Corp filed Critical Brigham and Womens Hospital Inc
Application granted granted Critical
Publication of DE60239407D1 publication Critical patent/DE60239407D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
DE60239407T 2001-04-27 2002-04-25 Okulare diagnose der alzheimer-krankheit Expired - Lifetime DE60239407D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28712401P 2001-04-27 2001-04-27
PCT/US2002/012945 WO2003018068A1 (en) 2001-04-27 2002-04-25 Ocular diagnosis of alzheimer's disease

Publications (1)

Publication Number Publication Date
DE60239407D1 true DE60239407D1 (de) 2011-04-21

Family

ID=23101559

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60239407T Expired - Lifetime DE60239407D1 (de) 2001-04-27 2002-04-25 Okulare diagnose der alzheimer-krankheit

Country Status (12)

Country Link
US (2) US6849249B2 (de)
EP (2) EP1420830B1 (de)
JP (2) JP2005511498A (de)
AT (1) ATE500850T1 (de)
AU (1) AU2002307526B2 (de)
CA (1) CA2458961C (de)
DE (1) DE60239407D1 (de)
DK (1) DK1420830T3 (de)
ES (1) ES2363729T3 (de)
NZ (2) NZ545889A (de)
PT (1) PT1420830E (de)
WO (1) WO2003018068A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297326B2 (en) * 2000-08-21 2007-11-20 The General Hospital Corporation Ocular diagnosis of Alzheimer's disease
EP2151187A1 (de) * 2000-08-21 2010-02-10 The General Hospital Corporation Verfahren zur Diagnose eines neurodegenerativen Leidens
EP1420830B1 (de) * 2001-04-27 2011-03-09 The General Hospital Corporation Okulare diagnose der alzheimer-krankheit
EP1631561B1 (de) 2003-05-07 2010-08-18 General Electric Company Zusammensetzungen und verfahren zur in vivo abbildung von loeslichen beta-amyloid
US20040223912A1 (en) * 2003-05-07 2004-11-11 Montalto Michael Christopher Compositions and methods for non-invasive imaging of soluble beta-amyloid
WO2005042461A1 (ja) * 2003-10-30 2005-05-12 Dojindo Laboratories アミロイド親和性化合物
EP1814876A2 (de) * 2004-07-15 2007-08-08 The General Hospital Corporation Heterozyklische farbstoffverbindungen für in-vivo-bilderzeugung und diagnose von alzheimer-krankheit
US7384146B2 (en) * 2005-06-28 2008-06-10 Carestream Health, Inc. Health care kiosk having automated diagnostic eye examination and a fulfillment remedy based thereon
EP1937286B1 (de) 2005-09-12 2016-03-09 Abela Pharmaceuticals, Inc. Zusammensetzungen aus dimethylsulfoxid (dmso)
JP5399072B2 (ja) 2005-09-12 2014-01-29 アベラ ファーマスーティカルズ インコーポレイテッド ジメチルスルホキシド（ｄｍｓｏ）若しくは関連化合物、又はそれに関連する臭気を除去するシステム
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
JP2007127592A (ja) * 2005-11-07 2007-05-24 Tohoku Univ アミロイド蓄積性疾患の新規診断用装置およびその操作方法
JP5170783B2 (ja) 2006-04-11 2013-03-27 コグノプティックス， インコーポレイテッド 眼の画像化
WO2008144065A1 (en) * 2007-05-21 2008-11-27 Neuroptix Corporation Ophthalmic formulations of amyloid- contrast agents and methods of use thereof
AU2009229348B2 (en) * 2008-03-27 2013-09-19 Cognoptix, Inc. Ocular imaging
US20090287064A1 (en) * 2008-05-15 2009-11-19 Medical Interactive Education, Llc Computer implemented cognitive self test
EP2323696B1 (de) * 2008-09-18 2018-09-05 Cedars-Sinai Medical Center Optisches verfahren zur erkennung der alzheimer-krankheit
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
US20120094308A1 (en) 2009-07-23 2012-04-19 Universidad Complutense De Madrid Kit and method for the premortem in vitro detection of alzheimer's disease
AU2010313253B2 (en) 2009-10-30 2015-02-19 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
MX357628B (es) 2010-08-16 2018-07-17 Cognoptix Inc Star Sistema y metodo para detectar proteinas amiloides.
EP3922270A1 (de) 2011-12-09 2021-12-15 Regents of the University of Minnesota Hyperspektrale bildgebung zur früherkennung von morbus alzheimer
AU2016209550A1 (en) * 2015-01-20 2017-08-03 Veloce Biopharma Llc Novel iodophor composition and methods of use
AU2017229876A1 (en) 2016-03-10 2018-11-01 Regents Of The University Of Minnesota Spectral-spatial imaging device
AU2018372578A1 (en) 2017-11-27 2020-06-11 Retispec Inc. Hyperspectral image-guided raman ocular imager for Alzheimer's Disease pathologies
CN113527347B (zh) * 2021-07-15 2023-12-08 淮阴工学院 近红外荧光标记脂肪酸及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171846A (en) * 1990-05-21 1992-12-15 Coulter Corporation Method of preferential labelling of a phycobiliprotein with a second dye for use in a multiple color assay and product for such use
US5595883A (en) * 1990-06-01 1997-01-21 E. R. Squibb & Sons, Inc. Method of diagnosing alzheimer's disease by measuring acetylcholinesterase activity in ocular fluid
US6198532B1 (en) 1991-02-22 2001-03-06 Applied Spectral Imaging Ltd. Spectral bio-imaging of the eye
US5434050A (en) 1991-08-13 1995-07-18 Regents Of The University Of Minnesota Labelled β-amyloid peptide and methods of screening for Alzheimer's disease
PT101290B (pt) 1993-06-18 2000-10-31 Fernandes Jose Guilherme Da Cu Fluorometro para medicao da concentracao de fluoroforos de localizacao ocular
US6417178B1 (en) * 1994-07-19 2002-07-09 University Of Pittsburgh Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
US6168776B1 (en) 1994-07-19 2001-01-02 University Of Pittsburgh Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
WO1997026919A2 (en) * 1996-01-24 1997-07-31 Warner-Lambert Company Method of imaging amyloid deposits
US6054114A (en) 1996-05-08 2000-04-25 Massachusetts Institute Of Technology Organometallic ligands for the localization and quantification of amyloid in vivo and in vitro
DE19649971A1 (de) * 1996-11-19 1998-05-28 Diagnostikforschung Inst Optische Diagnostika zur Diagnostik neurodegenerativer Krankheiten mittels Nahinfrarot-Strahlung (NIR-Strahlung)
EP1003539A4 (de) * 1997-08-14 2002-09-11 Univ California FLUORESZIERENDE AMYLOID A beta PEPTIDE UND DEREN VERWENDUNG
WO1999057566A1 (en) 1998-05-01 1999-11-11 The University Of Tennessee Research Corporation Flow cytometric characterization of amyloid fibrils
US6399314B1 (en) * 1999-12-29 2002-06-04 American Cyanamid Company Methods of detection of amyloidogenic proteins
EP2151187A1 (de) * 2000-08-21 2010-02-10 The General Hospital Corporation Verfahren zur Diagnose eines neurodegenerativen Leidens
US7297326B2 (en) * 2000-08-21 2007-11-20 The General Hospital Corporation Ocular diagnosis of Alzheimer's disease
AU2002211517A1 (en) * 2000-10-04 2002-04-15 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
EP1420830B1 (de) * 2001-04-27 2011-03-09 The General Hospital Corporation Okulare diagnose der alzheimer-krankheit

Also Published As

Publication number Publication date
US6849249B2 (en) 2005-02-01
CA2458961C (en) 2008-07-08
ES2363729T3 (es) 2011-08-12
US20050095653A1 (en) 2005-05-05
ATE500850T1 (de) 2011-03-15
EP2298361A2 (de) 2011-03-23
NZ531337A (en) 2006-05-26
DK1420830T3 (da) 2011-05-09
US20020182152A1 (en) 2002-12-05
EP1420830B1 (de) 2011-03-09
WO2003018068A1 (en) 2003-03-06
JP2009280594A (ja) 2009-12-03
EP1420830A1 (de) 2004-05-26
EP2298361A3 (de) 2011-05-04
NZ545889A (en) 2006-06-30
JP2005511498A (ja) 2005-04-28
PT1420830E (pt) 2011-04-20
AU2002307526B2 (en) 2006-08-24
EP1420830A4 (de) 2008-12-31
CA2458961A1 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
DE60239407D1 (de) Okulare diagnose der alzheimer-krankheit
ATE456055T1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
ATE283485T1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
WO2007011834A3 (en) Compounds and method for the diagnosis and treatment of amyloid associated diseases
HK1113160A1 (en) Methods for the diagnosis of dementia and other neurological disorders
WO2005020784A3 (en) Surrogate cell gene expression signatures for evaluating the physical state of a subject
BR0316231A (pt) Métodos para determinar o estado de sepsia para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo e para isolar um biomarcador, perfil biomarcador r kit
BRPI0413556A (pt) sondas para doenças onde amilóide se acumula, agentes para tingimento de amilóide, drogas para tratamento e profilaxia de doenças com amilóide acumulada e sondas para diagnóstico de emaranhados neurofibrilares e agentes para tingimento de emaranhados neurofibrilares
GB0512401D0 (en) Method
NO20050186L (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
DK1953556T3 (da) Polypeptidbiomarkører til diagnose af Alzheimer's sygdom
JP2005511498A5 (de)
ATE530667T1 (de) Kcnn3 als diagnostisches und therapeutisches target für alzheimer-krankheit
ATE415632T1 (de) Verfahren zur diagnose und behandlung von morbus crohn
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
EA200501620A1 (ru) Лечение состояний, включающих амилоидные бляшки
ATE546547T1 (de) Diagnose der chronischen abstossung
CY1111464T1 (el) Οφθαλμικη διαγνωση της ασθενειας alzheimer
ATE459877T1 (de) Diagnostikum für die frühe phase von morbus alzheimer
WO2005029089A3 (en) Method of diagnosing ovarian endometriosis using tfpi-2 protein
ATE449964T1 (de) DIAGNOSTISCHE VERWENDUNG VON ßENSADIN-0477ß FÜR NEURODEGENERATIVE ERKRANKUNGEN
ATE323408T1 (de) Transgenes tiermodell für neurodegenerative erkrankungen
BR0313667A (pt) Processos para diagnóstico de distúrbios neurológicos relacionados à demência
WO2006002563A3 (en) Method of assaying for a neurodegenerative disorder in an animal
AU4753900A (en) Methods of diagnosing or treating alzheimer's disease